In MPTP PD mouse, resveratrol emerges as a powerful ally for the gut microbiome, enhancing its potential and bolstering the intestinal barrier’s functionality.[198] Remarkably, through the innovative approach of fecal microbiota transplantation, it corrects the imbalance within the gut microbiome, leading to a reduction in intestinal TNF-α, IL-6, and IL-1β levels. The gene discussed is IL6; the disease is Parkinson disease.